Business, energy, technology, markets and global industry news from Business News Today

PPL-001

PharmaDeviceNews PPL-001
Automated cell therapy manufacturing could help Cellares and Papillon Therapeutics advance PPL-001 toward clinical development for Friedreich’s ataxia. Representative image.
Pharma & Biotech

Can Cellares automation move Papillon’s PPL-001 closer to a Friedreich’s ataxia trial?

Cellares will automate PPL-001 manufacturing for Friedreich’s ataxia, but IND-enabling work and human evidence remain ahead.

Read More